Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 17Uterine Cervical Neoplasms 11Stomach Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Ovarian Neoplasms 8Neoplasms 8Esophageal Neoplasms 8Carcinoma, Ovarian Epithelial 7Fallopian Tube Neoplasms 6Colorectal Neoplasms 5Recurrence 4Neoplasm Metastasis 4Multiple Myeloma 4Mouth Neoplasms 4Head and Neck Neoplasms 4Esophageal Squamous Cell Carcinoma 4Colonic Neoplasms 4Carcinoma, Hepatocellular 4Rectal Neoplasms 3Nasopharyngeal Carcinoma 3Lymphoma, Non-Hodgkin 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Glioblastoma 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Peripheral Nervous System Diseases 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

ledipasvir, sofosbuvir drug combination 1ledipasvir 1daclatasvir 1Sofosbuvir 1Simeprevir 1Ribavirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × OTHER_GOV × Hepatitis C, Chronic × Clear all
NCT02771405 2026-04-13

FRI-STC

National Hepatology & Tropical Medicine Research Institute

Phase 3 Completed
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡